Biocon's Shaw Urges Focus on Innovation in Pharma Industry
Kiran Mazumdar-Shaw stressed the need for an innovation-driven pharmaceutical sector in India. She called for ongoing investment in research and regulatory reforms to boost drug development. Shaw emphasized maintaining high-quality standards and closer collaboration between industry and regulators to sustain progress. India has strong potential to engage actively in the global innovation ecosystem.
Economic Times·



